fluoxetine has been researched along with Binge-Eating Disorder in 8 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Binge-Eating Disorder: A disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Antidepressants are commonly used to treat bulimia nervosa; high-dose fluoxetine is a standard approach, but many other antidepressants can be used." | 5.01 | Pharmacologic Treatment of Eating Disorders. ( Crow, SJ, 2019) |
| "This study aimed to evaluate whether genetic reductions in brain serotonin influence binge eating and/or the ability of fluoxetine, a selective serotonin reuptake inhibitor, to reduce binge eating in mice." | 4.12 | Brain serotonin deficiency and fluoxetine lead to sex-specific effects on binge-like food consumption in mice. ( Baugher, BJ; Huq, SN; Karth, MD; Karth, MM; Pellechia, SA; Sachs, BD; Warner, AK, 2022) |
| "Fluoxetine for BN and lisdexamfetamine for BED are relatively safe and well-tolerated." | 2.58 | Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder. ( Bello, NT; Yeomans, BL, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karth, MD | 1 |
| Baugher, BJ | 1 |
| Pellechia, SA | 1 |
| Huq, SN | 1 |
| Warner, AK | 1 |
| Karth, MM | 1 |
| Sachs, BD | 1 |
| Fornaro, M | 1 |
| Mondin, AM | 1 |
| Billeci, M | 1 |
| Fusco, A | 1 |
| De Prisco, M | 1 |
| Caiazza, C | 1 |
| Micanti, F | 1 |
| Calati, R | 1 |
| Carvalho, AF | 1 |
| de Bartolomeis, A | 1 |
| Himmerich, H | 1 |
| Treasure, J | 1 |
| Bello, NT | 1 |
| Yeomans, BL | 1 |
| Crow, SJ | 1 |
| Czyzyk, TA | 1 |
| Sahr, AE | 1 |
| Statnick, MA | 1 |
| Grilo, CM | 2 |
| Masheb, RM | 2 |
| Crosby, RD | 2 |
| Wilson, GT | 1 |
4 reviews available for fluoxetine and Binge-Eating Disorder
| Article | Year |
|---|---|
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials.
Topics: Anorexia Nervosa; Antipsychotic Agents; Binge-Eating Disorder; Bulimia Nervosa; Feeding and Eating D | 2023 |
Psychopharmacological advances in eating disorders.
Topics: Animals; Anorexia Nervosa; Binge-Eating Disorder; Bulimia Nervosa; Drug Design; Fluoxetine; Humans; | 2018 |
Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder.
Topics: Binge-Eating Disorder; Bulimia Nervosa; Fluoxetine; Humans; Lisdexamfetamine Dimesylate; Medication | 2018 |
Pharmacologic Treatment of Eating Disorders.
Topics: Anorexia Nervosa; Antidepressive Agents, Second-Generation; Binge-Eating Disorder; Bulimia Nervosa; | 2019 |
2 trials available for fluoxetine and Binge-Eating Disorder
| Article | Year |
|---|---|
Predictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorder.
Topics: Adolescent; Adult; Affect; Binge-Eating Disorder; Body Image; Body Mass Index; Cognitive Behavioral | 2012 |
12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder.
Topics: Adolescent; Adult; Binge-Eating Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; D | 2012 |
2 other studies available for fluoxetine and Binge-Eating Disorder
| Article | Year |
|---|---|
Brain serotonin deficiency and fluoxetine lead to sex-specific effects on binge-like food consumption in mice.
Topics: Animals; Binge-Eating Disorder; Brain; Bulimia; Female; Fluoxetine; Male; Mice; Serotonin | 2022 |
A model of binge-like eating behavior in mice that does not require food deprivation or stress.
Topics: Adiposity; Animals; Anti-Obesity Agents; Baclofen; Behavior, Animal; Binge-Eating Disorder; Body Wei | 2010 |